Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Anthem to buy Medicare Advantage insurer HealthSun

Insurance giant Anthem has announced it will acquire Florida Medicare Advantage plan HealthSun, which could add 40,000 members from the Miami metropolitan area to Anthem’s affiliated Medicare and Medicaid plans in the state.

How NC hospitals dealt with readmission penalties

Penalizing hospitals if patients are readmitted shortly after being discharged has appeared to work in change facilities' approach to care, according to WUNC’s look at several hospitals in the Triangle region of North Carolina.

Closed-loop control improves glycemic control in type 1 diabetic teens

Adolescence with type 1 diabetes (T1D) using closed-loop control (CLC) experienced improved glycemic control and reduced risk of hypoglycemia during exercise, according to a study published in Diabetes Care.

Thumbnail

UT officially names MD Anderson’s new president

The board of regents at the University of Texas (UT) finalized the selection of Peter Pisters, MD, MHCM, as the next president of the MD Anderson Cancer Center, a role which has sat vacant since the departure of Ronald DePinho, MD.

Thumbnail

Healthcare industry taking Graham-Cassidy ACA repeal bill more seriously

Once thought to be the policy equivalent of a Hail Mary pass, the plan to replace the Affordable Care Act (ACA) known as the Graham-Cassidy bill appears to have gained momentum—and with it, extra attention from healthcare industry groups like the American Medical Association (AMA) that have opposed Republicans’ so-far unsuccessful efforts to repeal the law.

The Qt Company Joins AdvaMed and MassMEDIC to Guide Policy and Technology Innovation in the Medical Device Industry

The Qt Company (HEX: QTCOM) today announced it will become a member of leading medical technology professional organizations AdvaMed and MassMEDIC, stepping into the integral role of industry advisor and enabler of technology innovation. In this role, Qt will influence the direction of the standards and regulations that govern the medical device industry on a global scale, and will help introduce new medical device technology advancements.

Thumbnail

Most hospital execs have limited cost reduction goals for next 5 years

More than half (51 percent) of hospital and health system executives responding to a Kaufman Hall survey said they have either no cost reduction goals or a goal of only a 1 percent to 5 percent reduction in the next five years.

Scribes improve physician satisfaction, chart accuracy

Medical scribes are tasked with clinical documentation, but what impact to these individuals have on physician and patient satisfaction or charting efficiency? A study published in the Annals of Family Medicine evaluated scribes in their abilities to ease clinical workflow.

Displaying 4225 - 4232 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup